NovaBridge Biosciences Operating Lease, Liability, Current
NovaBridge Biosciences (NBP) had Operating Lease, Liability, Current of $891.00 thousand as of 2025-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-04-07
- 2023-12-31: Operating Lease, Liability, Current 21.89M CNY.
- 2022-12-31: Operating Lease, Liability, Current 23.96M CNY.
- 2022-06-30: Operating Lease, Liability, Current 42.53M CNY.
- 2021-12-31: Operating Lease, Liability, Current 30.67M CNY.
CNY
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2023-12-31 | 21.89M CNY 20-F · filed 2024-04-30 |
| 2022-12-31 | 23.96M CNY 20-F · filed 2024-04-30 |
| 2022-06-30 | 42.53M CNY 6-K · filed 2022-11-10 |
| 2021-12-31 | 30.67M CNY 20-F · filed 2023-05-01 |
| 2020-12-31 | 8.06M CNY 20-F · filed 2022-04-29 |
| 2020-09-30 | 8.00M CNY 6-K · filed 2021-02-05 |
| 2019-12-31 | 6.81M CNY 20-F · filed 2021-04-28 |
USD
| Period end | Operating Lease, Liability, Current | Operating Lease, Liability, Current as first filed |
|---|---|---|
| 2025-12-31 | $891.00K 20-F · filed 2026-04-07 | |
| 2025-09-30 | $872.00K 6-K · filed 2025-12-18 | |
| 2025-06-30 | $853.00K 6-K · filed 2025-10-06 | |
| 2024-12-31 | $816.00K 20-F · filed 2026-04-07 | |
| 2023-12-31 | $626.00K 20-F · filed 2025-04-03 | $3.08M 20-F · filed 2024-04-30 |
| 2022-12-31 | $3.47M 20-F · filed 2023-05-01 | |
| 2022-06-30 | $6.35M 6-K · filed 2022-11-10 | |
| 2021-12-31 | $4.81M 20-F · filed 2022-04-29 | |
| 2020-12-31 | $1.24M 20-F · filed 2021-04-28 | |
| 2020-09-30 | $1.18M 6-K · filed 2021-02-05 | |
| 2019-12-31 | $978.00K 20-F · filed 2020-04-29 |